Physicians warming to CBD drug for epilepsy, pharmaceutical maker tells investors

Broad physician adoption of a cannabis-derived epilepsy treatment is boosting sales for the only company with federal permission to sell cannabis products in the United States. London-based GW Pharmaceuticals told investors Monday that it notched $108 million in sales last quarter and $309 million for calendar 2019. The sales figures were released in advance of the company’s […]

Physicians warming to CBD drug for epilepsy, pharmaceutical maker tells investors is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs